Website stats and analysis

Centogene N.V. $ Million - Initial Public OfferingJoint Bookrunner Evolus, Inc. $ Million - Follow-OnJoint Bookrunner Innate Pharma S.A. $ Million - Initial NASDAQ ListingJoint Bookrunner

2.48 Rating by Usitestat

svbleerink.com was registered 6 years 3 days ago. It has a alexa rank of #1,735,504 in the world. It is a domain having .com extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, svbleerink.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 505
Daily Pageviews: 1,010

Estimated Valuation

Income Per Day: $ 3.00
Estimated Worth: $ 720.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 1,735,504
PageSpeed Score: 89 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

192.230.66.29

Hosted Country:

United States US

Location Latitude:

39.7392

Location Longitude:

-104.985

Traffic Classification

Total Traffic: No Data
Direct Traffic: 54.57%
Referral Traffic: 5.84%
Search Traffic: 36.40%
Social Traffic: 0.74%
Mail Traffic: 2.45%
Display Traffic: 0%

Search Engine Results For svbleerink.com

Home - SVB Leerink

- https://www.svbleerink.com/

We are champions of and strategic partners to those transforming the future of healthcare and life sciences. From startup to enterprise, we deliver the optimal solution for our...


SVB Leerink - Wikipedia

- https://en.wikipedia.org/wiki/SVB_Leerink

SVB Leerink is a specialist investment bank focusing on the healthcare sector, headquartered in Boston, MA. SVB Leerink offers capital markets capabilities, M&A advisory,...


SVB Leerink | LinkedIn

- https://www.linkedin.com/company/svb-leerink

SVB Leerink is a leading investment bank, specializing in healthcare and life sciences. The firm’s knowledge, experience and focus enable it to help its clients define and...


Working at SVB Leerink | Glassdoor

- https://www.glassdoor.com/Overview/Working-at-SVB-Leerink-EI_IE2854283.11,22.htm

Apr 28, 2020 · See what employees say it's like to work at SVB Leerink. Salaries, reviews, and more - all posted by employees working at SVB Leerink.


SVB Leerink LLC - Find Careers in Finance | OneWire.com

- https://www.onewire.com/Companies/Index/3596

Nov 28, 2020 · SVB Leerink partners with companies that develop and commercialize innovative products and services that are defining the future of healthcare. SVB Leerink LLC is...


SVBLeerink Downgrades Moderna (MRNA). Time to Sell?

- https://www.thestreet.com/streetlightning/stock-picks/svbleerink-downgrades-moderna-mrna-time-to-sell-vaccine-covid-coronavirus

SVBLeerink Downgrades MRNA. On Tuesday, before the opening bell, SVBLeerink Downgraded shares of Moderna (MRNA) from Market Perform to Underperform, lowering their target price...


SVB to Acquire Healthcare Investment Bank Leerink Partners ...

- https://www.svb.com/news/company-news/svb-financial-group-to-acquire-healthcare-investment-bank-leerink-partners

Strategic combination will strengthen SVB’s position as the leading financial services provider to Healthcare and Life Science Companies. SANTA CLARA, Calif. –– November 13,...


Zogenix Announces Closing of Public Offering of Common ...

- https://finance.yahoo.com/news/zogenix-announces-closing-public-offering-210510238.html

Zogenix, Inc. (ZGNX), a global pharmaceutical company developing rare disease therapies, announced today that it has closed its previously announced underwritten public offering...


Five Prime Announces Closing of Upsized Public Offering of ...

- https://www.businesswire.com/news/home/20201117006258/en/Five-Prime-Announces-Closing-of-Upsized-Public-Offering-of-Common-Stock

Nov 17, 2020 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics, Inc. (Nasdaq: FPRX) announced today the closing of its upsized underwritten public offering...


Twitter

- https://twitter.com/SVBLeerink

We would like to show you a description here but the site won’t allow us.


Spruce Biosciences Announces Pricing of Upsized Initial ...

- https://www.businesswire.com/news/home/20201008006094/en/Spruce-Biosciences-Announces-Pricing-of-Upsized-Initial-Public-Offering

Oct 08, 2020 · Copies of the final prospectus relating to the offering may be obtained, when available, from: Cowen and Company, LLC, c/o Broadridge Financial …


Leerink Partners LLC | LinkedIn

- https://www.linkedin.com/company/leerink

Banking jobs 34,070 open jobs Analyst jobs 76,197 open jobs Intern jobs


Jerry Joa - Senior Network En.. - Silicon Valley Bank ...

- https://www.zoominfo.com/p/Jerry-Joa/1801578148

Nov 05, 2020 · View Jerry Joa's business profile as Senior Network Engineer at Silicon Valley Bank. Find contact's direct phone number, email address, work history, and more.


Organogenesis Holdings Inc. (ORGO) Stock Price, News ...

- https://finance.yahoo.com/quote/ORGO

Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock. CANTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq:...


Intellia Therapeutics Announces Pricing of Public Offering ...

- https://www.globenewswire.com/news-release/2020/12/02/2137973/0/en/Intellia-Therapeutics-Announces-Pricing-of-Public-Offering-of-Common-Stock.html

Dec 02, 2020 · The final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and may be obtained, when available, from: …


Amicus Therapeutics Announces Public Offering of Common ...

- https://www.globenewswire.com/news-release/2019/05/29/1856704/0/en/Amicus-Therapeutics-Announces-Public-Offering-of-Common-Stock.html

May 29, 2019 · CRANBURY, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced it has commenced a $150 million underwritten public offering of …


VC-backed 908 Devices files for an IPO | Venture Capital ...

- https://www.venturecapitaljournal.com/vc-backed-908-devices-files-for-an-ipo/

Nov 30, 2020 · Copies of the preliminary prospectus, when available, may be obtained from: Cowen and Company, LLC, c/o Broadridge Financial Solutions, Attention: Prospectus...


Aptinyx Inc. - Aptinyx Announces Proposed Public Offering ...

- https://ir.aptinyx.com/press-releases/news-details/2020/Aptinyx-Announces-Proposed-Public-Offering-of-Common-Stock-1a29c36fe/default.aspx

Oct 20, 2020 · Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system...


Replimune Announces Proposed Public Offering | Replimune

- https://ir.replimune.com/news-releases/news-release-details/replimune-announces-proposed-public-offering-1

Oct 20, 2020 · BOSTON, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from...

Page Resources Breakdown

Homepage Links Analysis

Home - SVB Leerink
SVB Leerink LLC is a leading investment bank, specializing in healthcare. Our knowledge, experience and focus enable us to help our clients define and achieve their strategic, capital markets and investment objectives. We partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare. LEERINK Partners LLC is a member of FINRA/SIPC. For more information, please visit: www.www.svbleerink.com.

Website Inpage Analysis

H1 Headings: Not Applicable H2 Headings: Not Applicable
H3 Headings: 3 H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 3
Google Adsense: Not Applicable Google Analytics: UA-17672055-1

Two Phrase Analysis

Words Occurrences Density Possible Spam
News Events 3 1.485 % No
Select Research 2 0.99 % No
Healthcare Investment 2 0.99 % No
Financial Group 2 0.99 % No
SVB Financial 2 0.99 % No
SEC Rule 2 0.99 % No
bar bar 2 0.99 % No
Investment Bank 2 0.99 % No
Leerink Partners 2 0.99 % No
Million Initial 2 0.99 % No
Bank Leerink 2 0.99 % No
Players August 1 0.495 % No
August 2019 1 0.495 % No
Research > 1 0.495 % No
2019 Select 1 0.495 % No
Transactions News 1 0.495 % No
> Transactions 1 0.495 % No
Completes Acquisition 1 0.495 % No
Partners SVB 1 0.495 % No
Group to 1 0.495 % No

Four Phrase Analysis

Words Occurrences Density Possible Spam
Healthcare Investment Bank Leerink 2 0.99 % No
Investment Bank Leerink Partners 2 0.99 % No
SVB Financial Group Completes 1 0.495 % No
Financial Group Completes Acquisition 1 0.495 % No
Group Completes Acquisition of 1 0.495 % No
Events SVB Financial Group 1 0.495 % No
News Events SVB Financial 1 0.495 % No
Select Research > Transactions 1 0.495 % No
2019 Select Research > 1 0.495 % No
Research > Transactions News 1 0.495 % No
> Transactions News Events 1 0.495 % No
Transactions News Events SVB 1 0.495 % No
Completes Acquisition of Healthcare 1 0.495 % No
of Healthcare Investment Bank 1 0.495 % No
Financial Group to Acquire 1 0.495 % No
Group to Acquire Healthcare 1 0.495 % No
to Acquire Healthcare Investment 1 0.495 % No
Acquire Healthcare Investment Bank 1 0.495 % No
SVB Financial Group to 1 0.495 % No
Partners SVB Financial Group 1 0.495 % No

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Connection: keep-alive
Cache-Control: public, max-age=600
Content-Encoding: gzip
Content-Type: text/html; charset=UTF-8
Link: ; rel=shortlink
Referrer-Policy:
Server: nginx
Strict-Transport-Security: max-age=300
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
X-Pantheon-Styx-Hostname: styx-fe4-a-7cf6c95f57-2mqkt
X-Pingback: https://www.svbleerink.com/xmlrpc.php
X-Styx-Req-Id: 3acc7832-0361-11ea-a52f-620edb12b210
X-Xss-Protection: 1; mode=block
Date: Sun, 10 Nov 2019 02:24:32 GMT
X-Served-By: cache-mdw17330-MDW, cache-hhn4064-HHN
X-Cache: MISS, MISS
X-Cache-Hits: 0, 0
X-Timer: S1573352672.082912,VS0,VE514
Vary: Accept-Encoding, Cookie, Cookie
Age: 0
Accept-Ranges: bytes
Via: 1.1 varnish
transfer-encoding: chunked
X-Iinfo: 12-77396195-77396197 NNNN CT(0 4 0) RT(1573352671642 32) q(0 0 0 -1) r(5 5) U12
X-CDN: Incapsula

Domain Information

Domain Registrar: CSC Corporate Domains, Inc.
Registration Date: 2018-11-14 6 years 3 days 8 hours ago
Last Modified: 2019-07-13 5 years 4 months 1 week ago

Domain Nameserver Information

Host IP Address Country
ns1.p16.dynect.net 108.59.161.16 United States United States
ns2.p16.dynect.net 108.59.162.16 United States United States
ns3.p16.dynect.net 108.59.163.16 United States United States
ns4.p16.dynect.net 108.59.164.16 United States United States

DNS Record Analysis

Host Type TTL Extra
svbleerink.com A 570 IP: 192.230.66.29
svbleerink.com A 570 IP: 192.230.74.29
svbleerink.com NS 86400 Target: ns2.p16.dynect.net
svbleerink.com NS 86400 Target: ns3.p16.dynect.net
svbleerink.com NS 86400 Target: ns4.p16.dynect.net
svbleerink.com NS 86400 Target: ns1.p16.dynect.net
svbleerink.com SOA 600 MNAME: ns1.p16.dynect.net
RNAME: hostmaster.svbleerink.com
Serial: 23
Refresh: 3600
Retry: 600
Expire: 604800
svbleerink.com MX 600 Priority: 10
Target: mx1.leerink.iphmx.com
svbleerink.com MX 600 Priority: 10
Target: mx2.leerink.iphmx.com
svbleerink.com TXT 600 TXT: v=spf1
include:spf.protection.outlook.com
ip4:23.22.171.115 ip4:167.89.10.119/32
ip4:74.217.54.144/31 ip4:23.253.33.197
include:_spf.bluematrix.com
exists:%{i}.spf.leerink.iphmx.com ~all
svbleerink.com TXT 600 TXT: MS=ms38102148
svbleerink.com TXT 600 TXT: 5afj8tf7kdlih01909dhfiir9t

Top Organic Keyword

1. svb leerink
2. leerink partners
3. leerink
4. svb leerink jeffrey a. leerink
5. leerink capital

Top Paid Keyword

Not Applicable

Full WHOIS Lookup

Domain Name: SVBLEERINK.COM
Registry Domain ID:
2332229383_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.corporatedomains.com
Registrar URL:
http://www.cscglobal.com/global/web/csc/digital-brand-services.html/>Updated Date: 2019-07-13T04:46:20Z
Creation Date:
2018-11-13T18:48:12Z
Registry Expiry Date:
2029-07-13T04:35:47Z
Registrar: CSC Corporate Domains,
Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
8887802723
Domain Status: clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Name Server:
NS1.P16.DYNECT.NET
Name Server: NS2.P16.DYNECT.NET
Name
Server: NS3.P16.DYNECT.NET
Name Server:
NS4.P16.DYNECT.NET
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-11-10T02:24:38Z

Similarly Ranked Websites

Welcome to the new Faces of Gaming Character Sharing Community! -...

- masseffect2faces.com

Faces Of Gaming is a new community that allows gamers all around the world to share and display their characters and in-game creations.

1,735,524   $ 720.00

Scott Stapp - Scott Stapp - Purpose For Pain

- scottstapp.com

New single - Purpose For Pain available now

1,735,526   $ 720.00

Car Repairs, WOF & Services in Hamilton | Grimmer Motors Hamilton

- grimmermotors.co.nz

Car Repairs, WOF, Servicing and Inspections. Call Grimmer Motors for expert mechanics in Hamilton

1,735,534   $ 720.00

Rincon del Lector – Para amantes de la lectura

- rincondellector.es

1,735,545   $ 720.00

شرکت پالایش گاز بیدبلند

- nigc-bidboland.ir

پورتال شرکت ملی گاز ایران-پالایش گاز بیدبلند

1,735,556   $ 720.00